Global proton therapy market has been witnessing increasing collaboration activities with technology partners wherein companies are vying for integrating proton therapy capabilities with the latter’s existing radiation oncology systems and equipment.
The report “Global Proton Therapy Market (By Product - Equipment & Services; By Room Type - Single Room & Multi-Room; By Region - North America, Asia Pacific & Europe) Market Outlook 2025” provides an in-depth analysis of global proton therapy treatment market with focus on major regional market such as North America, Europe and Asia Pacific. North America is the world’s largest proton therapy market with high predominance in the US. Japan and China are major proton therapy markets in the Asia Pacific region. In Europe, Germany and the UK are major proton therapy centres. The proton therapy systems market by product has been segmented into Equipment and Services, with Equipment accounting for nearly 90% share of the market. The market is segmented into Single-room and Multi-room by room type.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global proton therapy market. The report has been segmented as follows:
Market Segmentation - Product
Market Segmentation - Room Type
- North America - The US
- Asia Pacific - Japan
- Europe - Germany & The UK
- IBA Proton Therapy Inc.
- Varian Medical Systems
- Hitachi Ltd
- Sumitomo Heavy Industries, limited
- Mevion Medical System, Inc.
- Protom International, Inc.
1. Executive Summary
2. Research Methodology
3. Proton Therapy
3.1.1 Types of Cancer Treatment
3.2.1 History of Proton Therapy
3.2.2 Benefits of Proton Therapy
3.2.3 Proton Therapy Devices
3.3 Proton Therapy - Technology
3.3.1 Pencil beam scanning systems
3.3.2 Uniform scanning systems
3.3.3 Passive scattering systems
4. Proton Therapy Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.1.1 Market Size by Value (Actual & Forecasted)
4.1.2 Market Size by Volume
4.1.3 Treatment Rooms
4.2 Market Share Analysis
4.2.1 Market Share by Product
4.2.3 Market Share by Room Type
4.2.4 Market Share by Region
5. Market Segmentation
5.1 By Product
188.8.131.52 Market Sizing (Actual & Forecasted)
184.108.40.206 Market Sizing (Actual & Forecasted)
5.2 By Room Type
5.2.1 Single-Room Type
220.127.116.11 Market Sizing (Actual & Forecasted)
5.2.2 Multi-Room Type
18.104.22.168 Market Sizing (Actual & Forecasted)
5.2.3 Multi-Room Type
22.214.171.124 Market Sizing (Actual & Forecasted)
6. Regional Analysis
6.1 North America
6.1.2 Proton Therapy Installed Base
6.1.3 Patient Treatment Volume
6.1.4 The US
126.96.36.199 Market Sizing (Actual & Forecasted)
6.2 Europe Proton Therapy Market
6.2.2 Proton Therapy Installed Base
6.2.3 Patient Treatment Volume
6.2.4 The UK
6.3 Asia Proton Therapy Market
6.3.2 Proton Therapy Installed Base
6.3.3 Patient Treatment Volume
7. Proton Therapy Market Dynamics
7.1 Industry Trends & Developments
7.1.1 Collaborations in the Industry
7.1.2 Rising Demand for Single-Room Treatment Facilities
7.1.3 Advent of Affordable Proton Therapy Equipment
7.1.4 Technological Advancements in the Industry
7.2 Growth Drivers
7.2.1 Rise in Prevalence of Cancer Cases
7.2.2 Growth in Geriatric Population
7.2.3 Higher Tobacco Consumption
7.2.4 Favorable Reimbursement Policies
7.2.5 Precise Delivery with Fewer Risks
7.3.1 High Costs Involved
7.3.2 Stringent Regulations
7.3.3 Capacity Gap
8. Competitive Landscape
8.1 Proton Therapy Systems Comparison
8.2 Market share by Competitors
8.2.1 Overall Market
8.2.3 Installed Base
8.2.4 Order Share
8.2.5 Market Share by Patients Treated
8.3 Market Share by Room Sales
8.3.2 North America
8.3.3 The US
8.3.5 Asia Pacific except for Europe
8.3.6 Europe and Rest of World
9. Company Profiles
9.1 IBA Proton Therapy Inc.
9.2 Varian Medical Systems
9.3 Hitachi Ltd.
9.4 Sumitomo Heavy Industries, Limited
9.6 Mevion Medical Systems, Inc.
9.7 Protom International, Inc.
Proton beam therapy is a type of particle therapy that uses photon ionizing radiation for irradiation of diseases tissues. It is the most advanced form of radiation therapy enhanced with precise dose sculpting capability. It is relatively a niche radiation therapy with minimal radiation exposure, successfully eradicating potential side-effects of other forms of conventional radiation therapies. The proton therapy systems market by technology has been segmented into pencil beam scanning systems, uniform scanning systems and passive scattering systems. Pencil beam scanning is the most precise method of proton beam delivery has the highest dosimetric advantage.
Proton therapy has garnered immense popularity and has become mainstream treatment modality in cancer treatment worldwide due to its precise and non-invasive nature. The growth of the industry is primarily attributed to rising in the prevalence of cancer, the growth of geriatric population, higher tobacco consumption, favourable reimbursement policies and precise delivery capability. However, major industry restraints include high costs involved, stringent regulations and capacity gap.
The report “Global Proton Therapy Market (By Product - Equipment & Services; By Room Type - Single Room & Multi-Room; By Region - North America, Asia Pacific & Europe) Market Outlook 2025” provides an in-depth analysis of the current scenario, detailed market outlook of global proton therapy market. The report provides detailed proton therapy market assessment across major markets such as North America, Asia Pacific and Europe. North America is the world’s largest proton therapy market, followed by Asia and Europe. In-depth analysis of proton therapy market in the aforementioned regions is done on the basis of an installed base, proton therapy facilities (operational and upcoming) as well as patient treatment volume in respective markets. Furthermore, market segmentation is done across products such as Equipment and Services; and treatment room types such as Single-room and Multi-room type.
Global proton therapy industry is highly consolidated with three major players - IBA Proton Therapy Inc., Varian Medical Systems and Hitachi Limited accounting for more than two-thirds of the market. Other major industry players operating in the global proton therapy market include Sumitomo Heavy Industries Limited, Mevion Medical System, Inc. and Protom International, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global proton therapy market.